Preliminary results of the Norwegian coordinated therapy project 1968-1969.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use*; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D009664:Norway; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014722:Vestibule, Labyrinth / Q000187:drug effects; D014786:Vision Disorders / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D004977:Ethambutol; D012293:Rifampin